A novel inhibitor of sirtuin: Elucidation of mode of action and molecular pathway in colorectal cancer cell line.

dc.contributor.author	Yi Jer, Tan
dc.date.accessioned	2018-07-23T04:07:28Z
dc.date.available	2018-07-23T04:07:28Z
dc.date.issued	2017-08
dc.description.abstract	Kanser kolon merupakan salah satu jenis kanser yang paling banyak didapati di seluruh dunia. Walaupun kebanyakan pesakit menunjukkan respon yang baik terhadap rawatan kimoterapi pada peringkat awal, akan tetapi terdapat banyak kes kanser berulang selepas rawatan yang disebabkan oleh kewujudan rintangan terhadap rawatan, maka wujudnya keperluan untuk membangunkan agen terapeutik baru untuk kanser kolorektal. Colorectal cancer (CRC) is one of the most common types of cancer worldwide. Although most patients are responsive to standard chemotherapy treatments at the initial stage of diagnosis, many succumb to relapse due to acquired chemoresistance, hence driving the need for the development of novel therapeutic agents for colorectal cancer.	en_US
dc.identifier.uri	http://hdl.handle.net/123456789/6000
dc.language.iso	en	en_US
dc.publisher	Universiti Sains Malaysia	en_US
dc.subject	Molecular	en_US
dc.subject	Cancer	en_US
dc.title	A novel inhibitor of sirtuin: Elucidation of mode of action and molecular pathway in colorectal cancer cell line.	en_US
dc.type	Thesis	en_US

Now showing 1 - 1 of 1